Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

2.

Development of guidance modules by the PDA to extend and/or eliminate periodic validation: a proposal to PDA Scientific Advisory Board.

Korczynski MS.

PDA J Pharm Sci Technol. 2003 Jul-Aug;57(4):245-8. No abstract available.

PMID:
14558698
3.

The effect of closure processing on the microbial inactivation of biological indicators at the closure-container interface.

Berger TJ, May TB, Nelson PA, Rogers GB, Korczynski MS.

PDA J Pharm Sci Technol. 1998 Mar-Apr;52(2):70-4.

PMID:
9610171
4.

The ISO draft international standard--aseptic processing of health care products.

Korczynski MS.

PDA J Pharm Sci Technol. 1996 May-Jun;50(3):189-95. No abstract available.

PMID:
8696783
5.

Carleton's corner. Should the United States pharmacopeia define manufacturing process limits?

Korczynski MS.

J Parenter Sci Technol. 1991 Mar-Apr;45(2):76. No abstract available.

PMID:
2051259
6.

PDA/FDA interactions.

Korczynski MS.

J Parenter Sci Technol. 1991 Mar-Apr;45(2):69. No abstract available.

PMID:
2051257
7.

PDA's global role.

Korczynski MS.

J Parenter Sci Technol. 1990 May-Jun;44(3):111-2. No abstract available.

PMID:
2115083
8.

PDA's response to FDA's "Guideline on sterile drug products produced by aseptic processing".

Akers JE, Agalloco JP, Carleton FJ, Korczynski MS.

J Parenter Sci Technol. 1988 Jul-Aug;42(4):114-7. No abstract available.

PMID:
3183865
9.

A review of current technology in parenteral manufacturing.

Akers JE, Agalloco JP, Carleton FJ, Korczynski MS.

J Parenter Sci Technol. 1988 Mar-Apr;42(2):53-6. No abstract available. Erratum in: J Parenter Sci Technol 1988 Jul-Aug;42(4):141.

PMID:
3385542
10.

Concepts and issues--container/closure microbial validation.

Korczynski MS.

J Parenter Drug Assoc. 1980 Jul-Aug;34(4):277-85. No abstract available.

PMID:
6902775
11.

Sterilization of parenteral solutions--an integrated program.

Korczynski MS, Peterson CL, Schawel K.

Bull Parenter Drug Assoc. 1975 May-Jun;29(3):146-52. No abstract available.

PMID:
1167312
12.

An approach to establishing parenteral solution sterilization cycles.

Korczynski MS, Peterson CL, Loshbaugh CC.

Bull Parenter Drug Assoc. 1974 Nov-Dec;28(6):270-7. No abstract available.

PMID:
4455323
13.

Cell envelope of an iron-oxidizing bacterium: studies of lipopolysaccharide and peptidoglycan.

Wang WS, Korczynski MS, Lundgren DG.

J Bacteriol. 1970 Oct;104(1):556-65.

14.

Kinetic studies of iron oxidation by whole cells of Ferrobacillus ferrooxidans.

Schnaitman CA, Korczynski MS, Lundgren DG.

J Bacteriol. 1969 Aug;99(2):552-7.

15.

Extracellular complex from the culture filtrate of Ferrobacillus ferrooxidans.

Agate AD, Korczynski MS, Lundgren DG.

Can J Microbiol. 1969 Mar;15(3):259-64. No abstract available.

PMID:
5781752
16.

Phospholipids from the chemoautotroph Ferrobacillus ferrooxidans.

Korczynski MS, Agate AD, Lundgren DG.

Biochem Biophys Res Commun. 1967 Nov 30;29(4):457-62. No abstract available.

PMID:
16496519

Supplemental Content

Loading ...
Support Center